• Help people with EB

    Your support of DEBRA International or a national EB group enables us to provide the best quality of life for families and individuals affected by EB.

Donation Account: IBAN AT65 6000 0005 1004 5254, BIC BAWAATWW, DEBRA International, Am Heumarkt 27/1, 1030 Vienna

donate now

10.11.2017

EB researchers break new ground with skin graft trial - what does this all mean and what happens next?

When is this available for me?

There are on-going clinical trials in a variety of research areas. This particular trial was in Germany, similar work is on-going in other countries. Clinical trials aim to make sure that a treatment is safe and works as planned in a suitable number of patients. Once this information can be confirmed, treatments are then made available. 

Can it be used for other types of EB?

While this trial was for Junctional Epidermolysis Bullosa, we hope that learning experiences will enable the research teams to replicate across all types of EB. But, this can be a complicated process and needs more research to determine if and how this would translate to other types of EB.

Is all research now only going to focus on those with severe cases?

Research will continue to cover all types of EB for quality of life treatments and, ultimately, a range of cures.

Is this a cure?

This is not a cure, but is a great move forward for this child and his family, as well as advances the science and knowledge we have about treating EB.

What is DEBRA doing to help with this?

DEBRA continues to support pioneering research with recent funding provided for projects on itch, wound healing and drug therapies.

Is this guaranteed to work for everyone?

Unfortunately, there are never any guarantees; however, it is great to see this has worked in this case and hopefully may be replicated for others in the future.

What are the next steps?

Each of these trials creates learning opportunities and moves forward. We hope experiences learned from this trial, and other similar work, will enable further studies and research with a focus on skin grafting, cell treatments and the use of gene editing.

Can this be done again?

We hope so! DEBRA will continue to focus on innovative research and clinical trials to help EB sufferers, replicating successes whenever possible.

What does this mean?

Cells were taken from this young boy’s skin affected by EB, corrected in a lab environment; new skin was grown and replaced.

How much does this cost?

Clinical trials typically cost in excess of £1 million – this particular trial is estimated to cost several million Euros.

If this trial has been successful, why do we need to fund further trials before we can start putting this into practice?

Clinical trials test treatments and medicines to make sure they are safe to use and work as planned; trials would normally involve a suitable number of patients. A larger number of patients will need to be treated, and more assessments made, to ensure that this is the case.

Why does this trial differ from other skin grafting trials, and why has this one worked?

A number of centres around the world are using skin grafting techniques and, of course, this has been carried out in patients with burns for a good number of years. What differs in this case is that the cells that were taken were genetically corrected before the skin was grown and used for patient treatment.

Following the results of this trial, are there plans for Germany to make this treatment available? If so, when?

This was a collaborative piece of work involving researchers and doctors from across Europe. Clinical trials will need to be continued to ensure that this treatment, and others like it, are safe and work as intended.

If I want my child to be involved in a trial what is the application process and timescale?

To take part in any type of clinical trial, the first person to speak with is your own doctor. They can talk to you about the trials they may be taking part in and assess if you may be medically suitable.

Image credit: Nature, taken from www.bbc.co.uk